Does ANAKINRA Cause Interstitial lung disease? 267 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 267 reports of Interstitial lung disease have been filed in association with ANAKINRA (Kineret). This represents 2.2% of all adverse event reports for ANAKINRA.
267
Reports of Interstitial lung disease with ANAKINRA
2.2%
of all ANAKINRA reports
68
Deaths
190
Hospitalizations
How Dangerous Is Interstitial lung disease From ANAKINRA?
Of the 267 reports, 68 (25.5%) resulted in death, 190 (71.2%) required hospitalization, and 112 (41.9%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ANAKINRA. However, 267 reports have been filed with the FAERS database.
What Other Side Effects Does ANAKINRA Cause?
Off label use (4,317)
Drug ineffective (3,368)
Pain (1,344)
Condition aggravated (1,339)
Rheumatoid arthritis (1,300)
Drug intolerance (946)
Joint swelling (921)
Injection site pain (879)
Product dose omission issue (864)
Arthralgia (850)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which ANAKINRA Alternatives Have Lower Interstitial lung disease Risk?
ANAKINRA vs ANAMORELIN
ANAKINRA vs ANASTROZOLE
ANAKINRA vs ANDEXANET ALFA
ANAKINRA vs ANDROGEL
ANAKINRA vs ANETHOLTRITHION